KYMRKymera Therapeutics, Inc.Aug 5, 2026Q2 2026
Read transcript →Kymera Therapeutics, Inc. (KYMR) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$115.29
-5.55%
Mkt Cap $9.69B
KYMRKymera Therapeutics, Inc.Aug 5, 2026KYMRKymera Therapeutics, Inc.Feb 26, 2026Q4 2025
Read transcript →KYMRKymera Therapeutics, Inc.Nov 4, 2025Q3 2025
Read transcript →KYMRKymera Therapeutics, Inc.Aug 11, 2025Q2 2025
Read transcript →KYMRKymera Therapeutics, Inc.May 9, 2025Q1 2025
Read transcript →KYMRKymera Therapeutics, Inc.Feb 27, 2025Q4 2024
Read transcript →KYMRKymera Therapeutics, Inc.Nov 3, 2024Q3 2024
Read transcript →KYMRKymera Therapeutics, Inc.Aug 10, 2024Q2 2024
Read transcript →KYMRKymera Therapeutics, Inc.May 2, 2024Q1 2024
Read transcript →KYMRKymera Therapeutics, Inc.Feb 22, 2024Q4 2023
Read transcript →KYMRKymera Therapeutics, Inc.Nov 4, 2023Q3 2023
Read transcript →KYMRKymera Therapeutics, Inc.Aug 6, 2023Q2 2023
Read transcript →KYMRKymera Therapeutics, Inc.May 6, 2023Q1 2023
Read transcript →KYMRKymera Therapeutics, Inc.Feb 25, 2023Q4 2022
Read transcript →KYMRKymera Therapeutics, Inc.Nov 6, 2022Q3 2022
Read transcript →KYMRKymera Therapeutics, Inc.Aug 10, 2022Q2 2022
Read transcript →KYMRKymera Therapeutics, Inc.May 3, 2022Q1 2022
Read transcript →